JP Stock MarketDetailed Quotes

3349 COSMOS Pharmaceutical

Watchlist
  • 6787.0
  • -134.0-1.94%
20min DelayNot Open Dec 13 15:30 JST
542.97BMarket Cap21.99P/E (Static)

COSMOS Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Aug 31, 2024
(FY)May 31, 2024
(Q4)May 31, 2024
(Q3)Feb 29, 2024
(Q2)Nov 30, 2023
(Q1)Aug 31, 2023
(FY)May 31, 2023
(Q4)May 31, 2023
(Q3)Feb 28, 2023
(Q2)Nov 30, 2022
Total revenue
8.35%261.84B
16.59%964.99B
12.77%249.68B
18.09%238.88B
18.64%234.78B
17.24%241.65B
9.57%827.7B
12.65%221.4B
7.74%202.29B
8.90%197.89B
Cost of revenue
6.49%207.28B
17.86%776.68B
13.59%201.04B
19.21%192.15B
20.31%188.86B
18.81%194.64B
9.11%658.98B
13.07%176.99B
7.11%161.19B
7.87%156.97B
Gross profit
16.06%54.56B
11.61%188.31B
9.53%48.64B
13.72%46.73B
12.21%45.92B
11.16%47.01B
11.40%168.72B
11.04%44.41B
10.30%41.1B
13.02%40.92B
Operating expense
13.05%42.98B
13.14%156.8B
12.16%40.88B
13.16%38.83B
13.47%39.07B
13.86%38.02B
13.92%138.59B
13.56%36.45B
13.10%34.32B
15.62%34.43B
Operating profit
28.80%11.58B
4.55%31.5B
-2.51%7.76B
16.53%7.9B
5.55%6.85B
1.02%8.99B
1.12%30.13B
0.81%7.96B
-1.99%6.78B
0.98%6.49B
Net non-operating interest income (expenses)
-375.00%-38M
-1,275.00%-55M
-600.00%-35M
-700.00%-6M
-700.00%-6M
-700.00%-8M
-4M
-350.00%-5M
1M
200.00%1M
Non-operating interest income
10.00%11M
-6.38%44M
-8.33%11M
0.00%12M
-8.33%11M
-9.09%10M
-9.62%47M
-14.29%12M
-7.69%12M
-7.69%12M
Non-operating interest expense
172.22%49M
94.12%99M
170.59%46M
63.64%18M
54.55%17M
50.00%18M
-1.92%51M
41.67%17M
-15.38%11M
-21.43%11M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
-268.85%-225M
-86.17%-579M
-300.66%-609M
723.08%162M
21.11%-71M
-41.86%-61M
-266.31%-311M
-38.18%-152M
-116.88%-26M
-139.30%-90M
Less:Restructuring and mergern&acquisition
-25.93%20M
-63.49%69M
-63.83%51M
-311.11%-19M
-58.33%10M
80.00%27M
20.38%189M
95.83%141M
-79.07%9M
-40.00%24M
Less:Other special charges
502.94%205M
-120.49%-25M
109.09%23M
-941.18%-143M
-7.58%61M
21.43%34M
135.47%122M
-71.05%11M
108.63%17M
124.54%66M
Less:Write off
----
--535M
----
----
----
----
--0
----
----
----
Other non-operating income (expenses)
5.03%751M
-3.61%2.85B
-10.34%659M
-5.35%672M
2.28%807M
-1.52%715M
-3.46%2.96B
-14.83%735M
3.35%710M
2.33%789M
Income before tax
25.22%12.07B
2.89%33.72B
-8.95%7.78B
16.89%8.73B
5.49%7.58B
0.57%9.64B
-0.83%32.77B
-1.27%8.54B
-3.78%7.47B
-3.23%7.18B
Income tax
25.38%3.92B
3.23%9.27B
-33.69%681M
19.17%2.96B
5.54%2.5B
0.94%3.13B
-9.27%8.98B
-47.33%1.03B
-2.70%2.48B
-2.27%2.37B
Net income
25.12%8.14B
2.76%24.45B
-5.55%7.1B
15.77%5.77B
5.42%5.08B
0.42%6.51B
2.77%23.8B
12.15%7.51B
-4.34%4.98B
-3.68%4.82B
Net income continuous operations
25.14%8.14B
2.76%24.45B
-5.56%7.1B
15.75%5.77B
5.46%5.08B
0.40%6.51B
2.77%23.8B
12.13%7.51B
-4.30%4.99B
-3.70%4.82B
Noncontrolling interests
Net income attributable to the company
25.12%8.14B
2.76%24.45B
-5.55%7.1B
15.77%5.77B
5.42%5.08B
0.42%6.51B
2.77%23.8B
12.15%7.51B
-4.34%4.98B
-3.68%4.82B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
25.12%8.14B
2.76%24.45B
-5.55%7.1B
15.77%5.77B
5.42%5.08B
0.42%6.51B
2.77%23.8B
12.15%7.51B
-4.34%4.98B
-3.68%4.82B
Gross dividend payment
Basic earnings per share
25.03%102.74
2.71%308.61
-5.62%89.54
15.67%72.805
5.36%64.09
0.41%82.175
2.77%300.48
12.14%94.87
-4.32%62.94
-3.68%60.83
Diluted earnings per share
25.03%102.74
2.71%308.61
-5.62%89.54
15.68%72.8005
5.35%64.0821
0.41%82.175
2.77%300.48
12.14%94.87
-4.34%62.931
-3.68%60.83
Dividend per share
0
20.00%60
4.35%30
0
41.18%30
0
25.00%50
43.75%28.75
0
6.25%21.25
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q1)Aug 31, 2024(FY)May 31, 2024(Q4)May 31, 2024(Q3)Feb 29, 2024(Q2)Nov 30, 2023(Q1)Aug 31, 2023(FY)May 31, 2023(Q4)May 31, 2023(Q3)Feb 28, 2023(Q2)Nov 30, 2022
Total revenue 8.35%261.84B16.59%964.99B12.77%249.68B18.09%238.88B18.64%234.78B17.24%241.65B9.57%827.7B12.65%221.4B7.74%202.29B8.90%197.89B
Cost of revenue 6.49%207.28B17.86%776.68B13.59%201.04B19.21%192.15B20.31%188.86B18.81%194.64B9.11%658.98B13.07%176.99B7.11%161.19B7.87%156.97B
Gross profit 16.06%54.56B11.61%188.31B9.53%48.64B13.72%46.73B12.21%45.92B11.16%47.01B11.40%168.72B11.04%44.41B10.30%41.1B13.02%40.92B
Operating expense 13.05%42.98B13.14%156.8B12.16%40.88B13.16%38.83B13.47%39.07B13.86%38.02B13.92%138.59B13.56%36.45B13.10%34.32B15.62%34.43B
Operating profit 28.80%11.58B4.55%31.5B-2.51%7.76B16.53%7.9B5.55%6.85B1.02%8.99B1.12%30.13B0.81%7.96B-1.99%6.78B0.98%6.49B
Net non-operating interest income (expenses) -375.00%-38M-1,275.00%-55M-600.00%-35M-700.00%-6M-700.00%-6M-700.00%-8M-4M-350.00%-5M1M200.00%1M
Non-operating interest income 10.00%11M-6.38%44M-8.33%11M0.00%12M-8.33%11M-9.09%10M-9.62%47M-14.29%12M-7.69%12M-7.69%12M
Non-operating interest expense 172.22%49M94.12%99M170.59%46M63.64%18M54.55%17M50.00%18M-1.92%51M41.67%17M-15.38%11M-21.43%11M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges) -268.85%-225M-86.17%-579M-300.66%-609M723.08%162M21.11%-71M-41.86%-61M-266.31%-311M-38.18%-152M-116.88%-26M-139.30%-90M
Less:Restructuring and mergern&acquisition -25.93%20M-63.49%69M-63.83%51M-311.11%-19M-58.33%10M80.00%27M20.38%189M95.83%141M-79.07%9M-40.00%24M
Less:Other special charges 502.94%205M-120.49%-25M109.09%23M-941.18%-143M-7.58%61M21.43%34M135.47%122M-71.05%11M108.63%17M124.54%66M
Less:Write off ------535M------------------0------------
Other non-operating income (expenses) 5.03%751M-3.61%2.85B-10.34%659M-5.35%672M2.28%807M-1.52%715M-3.46%2.96B-14.83%735M3.35%710M2.33%789M
Income before tax 25.22%12.07B2.89%33.72B-8.95%7.78B16.89%8.73B5.49%7.58B0.57%9.64B-0.83%32.77B-1.27%8.54B-3.78%7.47B-3.23%7.18B
Income tax 25.38%3.92B3.23%9.27B-33.69%681M19.17%2.96B5.54%2.5B0.94%3.13B-9.27%8.98B-47.33%1.03B-2.70%2.48B-2.27%2.37B
Net income 25.12%8.14B2.76%24.45B-5.55%7.1B15.77%5.77B5.42%5.08B0.42%6.51B2.77%23.8B12.15%7.51B-4.34%4.98B-3.68%4.82B
Net income continuous operations 25.14%8.14B2.76%24.45B-5.56%7.1B15.75%5.77B5.46%5.08B0.40%6.51B2.77%23.8B12.13%7.51B-4.30%4.99B-3.70%4.82B
Noncontrolling interests
Net income attributable to the company 25.12%8.14B2.76%24.45B-5.55%7.1B15.77%5.77B5.42%5.08B0.42%6.51B2.77%23.8B12.15%7.51B-4.34%4.98B-3.68%4.82B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 25.12%8.14B2.76%24.45B-5.55%7.1B15.77%5.77B5.42%5.08B0.42%6.51B2.77%23.8B12.15%7.51B-4.34%4.98B-3.68%4.82B
Gross dividend payment
Basic earnings per share 25.03%102.742.71%308.61-5.62%89.5415.67%72.8055.36%64.090.41%82.1752.77%300.4812.14%94.87-4.32%62.94-3.68%60.83
Diluted earnings per share 25.03%102.742.71%308.61-5.62%89.5415.68%72.80055.35%64.08210.41%82.1752.77%300.4812.14%94.87-4.34%62.931-3.68%60.83
Dividend per share 020.00%604.35%30041.18%30025.00%5043.75%28.7506.25%21.25
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Top JP Stock Gainers
Symbol Price % Chg
Sakurasaku Plus
7097
1315 +29.56%
Timee
215A
1490 +25.21%
Wintest
6721
80 +25.00%
Heartseed
219A
1941 +24.42%
Raksul
4384
1334 +20.61%

See the daily top gainer.